| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |